Pharmaids Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Pharmaids Pharmaceuticals Ltd. on BSE

Load latest

Pharmaids Pharmaceuticals Ltd.

05 Dec 2024

61.00

1.79%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) …

BSE India

Pursuant to regulation 7(2)(b) of SEBI (PIT) Regulation, 2015 Company has received ''Form B'' from Mr.Shreedhara Shetty, Non Executive & Non Independent Director, in respect of sale of equity shares of the Company.

pdf

Pharmaids Pharmaceuticals Ltd.

03 Dec 2024

61.00

1.79%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) …

BSE India

Pursuant to regulation 7(2)(b) of SEBI (PIT) Regulation 2015, Company has received ''Form B'' from Mr.Shreedhara Shetty, Non Executive & Non Independent Director, in respect of sale of equity shares of the Company.

pdf

Pharmaids Pharmaceuticals Ltd.

02 Dec 2024

61.00

1.79%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) …

BSE India

Pursuant to Regulation 7(2)(b) of SEBI (PIT) Regulation, 2015, Company has received ''Form B'' from Mr.Shreedhara Shetty, Non Executive Non Independent Director, in respect of sale of equity shares of the Company.

pdf

Pharmaids Pharmaceuticals Ltd.

28 Nov 2024

61.00

1.79%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) …

BSE India

Pursuant to regulation 7(2)(b) of SEBI (PIT) Regulation, 2015, Company has received "Form B" from Mr.Shreedhara Shetty, Non Executive & Non Independent Director, in respect of sale of equity shares of the Company.

pdf

Pharmaids Pharmaceuticals Ltd.

14 Nov 2024

61.00

1.79%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI Listing Regulations, 2015, enclosed herewith the copies of newspaper publications providing extracts of unaudited financial results for the quarter and half year ended on September 30, 2024.

pdf

Pharmaids Pharmaceuticals Ltd.

13 Nov 2024

61.00

1.79%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 30 - Contact Details Of KMP For …

BSE India

Intimation of details of KMP for determining materiality of event/ information and making disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Pharmaids Pharmaceuticals Ltd.

13 Nov 2024

61.00

1.79%

Result

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Financial Results For The Quarter And Half Year Ended September …

BSE India

Financial Results for the Quarter and Half year ended September 30, 2024

pdf

Pharmaids Pharmaceuticals Ltd.

13 Nov 2024

61.00

1.79%

Board Meeting

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Board Meeting Outcome for Board Meeting Outcome For Declaration Of …

BSE India

Outcome of the Board Meeting held on 13th November, 2024, to consider and approve the un-audited financial results for the quarter and half year ended 30th September, 2024.

pdf

Pharmaids Pharmaceuticals Ltd.

09 Nov 2024, 02:47PM

61.00

1.79%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 30 (LODR) - Intimation On Loan Agreement.

BSE India

Disclosure under regulation 30 of SEBI (LODR) Regulations, 2015 - Intimation on Loan Agreement

pdf

Pharmaids Pharmaceuticals Ltd.

07 Nov 2024

61.00

1.79%

Board Meeting

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial …

BSE India

PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended 30th September 2024.

pdf

Is Pharmaids Pharmaceuticals Ltd. worth buying?

13 Votes:

Buy 53.85%

Sell 30.77%

Hold 15.38%